# OnCo record mansoor-raza-mirza (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/mansoor-raza-mirza/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "mansoor-raza-mirza" ;
  schema:name "Mansoor Raza Mirza"@en ;
  schema:description "Led NOVA and RUBY, the trials that established niraparib maintenance in ovarian cancer and dostarlimab in advanced endometrial cancer."@en ;
  schema:url <https://onco.cc/people/mansoor-raza-mirza/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=Mirza%20MR%5BAuthor%5D%20niraparib%20OR%20dostarlimab> ;
  onco:tag "endometrial", "ovarian", "trialist" ;
  schema:jobTitle "Chief Oncologist, Rigshospitalet, Copenhagen University Hospital; Chair, ENGOT" ;
  schema:sameAs <https://orcid.org/0000-0002-8085-1010> ;
  onco:cancers <https://onco.cc/cancers/endometrial/>, <https://onco.cc/cancers/ovarian/> ;
  onco:technologies <https://onco.cc/technologies/parp-inhibitor/>, <https://onco.cc/technologies/checkpoint-inhibitor/> ;
  onco:targets <https://onco.cc/targets/parp/>, <https://onco.cc/targets/pd1/> ;
  onco:drugs <https://onco.cc/drugs/niraparib/>, <https://onco.cc/drugs/dostarlimab/> ;
  onco:companies <https://onco.cc/companies/nordic-lymphoma-group/> ;
  onco:institutions <https://onco.cc/institutions/rigshospitalet/> ;
  onco:trials <https://onco.cc/trials/ruby/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-ruby-nejm-2023/> ;
  schema:affiliation <https://onco.cc/institutions/rigshospitalet/> .